The Hard Part with Evan McCann Richard Waines from DCVC Bio
Richard Waines is an Investor at DCVC Bio.
DCVC Bio invests in early-stage, deep-tech life science companies that are leveraging computational approaches, including AI and automation, to transform existing technologies and accelerate the development of new ones.
Chapters/Takeaways
03:19 → Journey into Biotech Investing
11:53 → DCVC Bio's Focus and Investment Strategy
16:19 → Exploring Platform Therapeutics in Biotech
20:15 → Nuances of Biotech Investing vs. Other Industries
23:11 → Managing Science Risk in Biotech Investments
27:58 → Key Personnel Changes During Company Growth
30:24 → Geographical Considerations in Biotech Investments
34:30 → The Passion for Science vs. Business in Biotech
36:08 → The Role of an Associate in Venture Capital
41:17 → The Impact of AI on Biotech Investments